Hudson Valley Investment Advisors’s AstraZeneca AZN Stock Holding History

Hudson Valley Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,188	Closed	-$203K	–	154
2015 Q2	$203K	Sell	3,188 -725	-19%	-$49.6K	0.06%	137
2015 Q1	$268K	Sell	3,913 -350	-8%	-$24.3K	0.09%	111
2014 Q4	$300K	Sell	4,263 -12	-0.3%	-$859	0.12%	99
2014 Q3	$305K	Sell	4,275 -910	-18%	-$66.6K	0.13%	99
2014 Q2	$385K	Sell	5,185 -1,770	-25%	-$128K	0.17%	88
2014 Q1	$451K	Buy	6,955 +325	+5%	+$21K	0.19%	82
2013 Q4	$394K	Sell	6,630 -50	-0.7%	-$2.72K	0.17%	90
2013 Q3	$347K	Hold	6,680	–	–	0.17%	93
2013 Q2	$316K	Buy	+6,680	New	+$340K	0.15%	97

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Hudson Valley Investment Advisors's AZN Position: Q3 2015 in Review

Hudson Valley Investment Advisors sold out of AstraZeneca (AZN) in Q3 2015, closing a stake of 3,188 shares — an estimated $203K sold.

Hudson Valley Investment Advisors first reported a position in AZN in Q2 2013 and held it in 9 quarters. The position peaked at $451K in Q1 2014. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

Hudson Valley Investment Advisors reported no remaining AstraZeneca position as of Q3 2015 after selling out during the quarter.
Hudson Valley Investment Advisors sold 3,188 AstraZeneca shares in Q3 2015, an estimated $203K.
Hudson Valley Investment Advisors first reported a position in AstraZeneca in Q2 2013 and held it in 9 quarters.
Hudson Valley Investment Advisors's AstraZeneca position peaked at $451K in Q1 2014.
371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on Hudson Valley Investment Advisors's 13F filing for Q3 2015, filed 16 Oct 2015.